Bai Yaqiang, Tao Jia, Zhou Jiaorui, Fan Qingjie, Liu Man, Hu Yuqi, Xu Yao, Zhang Lilong, Yuan Jieli, Li Wenzhe, Ze Xiaolei, Malard Patrice, Guo Zhimou, Yan Jingyu, Li Ming
College of Basic Medical Science, Dalian Medical University, Dalian, China.
Department of Gynaecology and Obstetrics, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
mSystems. 2018 Dec 26;3(6). doi: 10.1128/mSystems.00206-18. eCollection 2018 Nov-Dec.
The milk glycobiome has a significant impact on the gut microbiota of infants, which plays a pivotal role in health and development. Fucosylated human milk oligosaccharides (HMOs) and N-glycans on milk proteins are beneficial for the development of healthy gut microbiota, and the fucosylation levels of these glycans can be affected by the maternal fucosyltransferase 2 gene (). Here, we present results of longitudinal research on paired milk and stool samples from 56 Chinese mothers (CMs) and their breast-fed children. Changes of HMOs and fucosylated N-glycans in milk of CMs at different lactation stages were detected, which allowed characterization of the major differences in milk glycans and consequential effects on the gut microbiome of infants according to maternal status. Significant differences in the abundance of total and fucosylated HMOs between secretor and nonsecretor CMs were noted, especially during early lactation. Despite a tendency toward decreasing milk protein concentrations, the fucosylation levels of milk N-glycans increased during late lactation. The changes in the levels of fucosylated HMOs and milk N-glycans were highly correlated with the growth of spp. and spp. in the gut of infants during early and later lactation, respectively. Enriched expression of genes encoding glycoside hydrolases, glycosyl transferases, ATP-binding cassette (ABC) transporters, and permeases in infants fed by secretor CMs contributed to the promotion of these bacteria in infants. Our data highlight the important role of fucosylated milk glycans in shaping the gut microbiome of infants and provide a solid foundation for development of "personalized" nutrition for Chinese infants. Human milk glycans provide a broad range of carbon sources for gut microbes in infants. Levels of protein glycosylation in human milk vary during lactation and may also be affected by the stages of gestation and lactation and by the secretor status of the mother. This was the first study to evaluate systematically dynamic changes in human milk oligosaccharides and fucosylated N-glycans in the milk of Chinese mothers with different secretor statuses during 6 months of lactation. Given the unique single nucleotide polymorphism site (rs1047781, A385T) on the fucosyltransferase 2 gene among Chinese populations, our report provides a specific insight into the milk glycobiome of Chinese mothers, which may exert effects on the gut microbiota of infants that differ from findings from other study cohorts.
母乳糖组对婴儿的肠道微生物群有重大影响,而肠道微生物群在健康和发育中起着关键作用。岩藻糖基化的人乳寡糖(HMOs)和乳蛋白上的N-聚糖有利于健康肠道微生物群的发育,这些聚糖的岩藻糖基化水平可能受母体岩藻糖基转移酶2基因()的影响。在此,我们展示了对56位中国母亲(CMs)及其母乳喂养的孩子的配对母乳和粪便样本进行纵向研究的结果。检测了不同泌乳阶段CMs母乳中HMOs和岩藻糖基化N-聚糖的变化,从而能够根据母体状态表征母乳聚糖的主要差异以及对婴儿肠道微生物群的相应影响。发现分泌型和非分泌型CMs之间总HMOs和岩藻糖基化HMOs丰度存在显著差异,尤其是在泌乳早期。尽管母乳蛋白质浓度有下降趋势,但母乳N-聚糖的岩藻糖基化水平在泌乳后期有所增加。岩藻糖基化HMOs和母乳N-聚糖水平的变化分别与婴儿早期和后期肠道中 菌属和 菌属的生长高度相关。由分泌型CMs喂养的婴儿中编码糖苷水解酶、糖基转移酶、ATP结合盒(ABC)转运蛋白和通透酶的基因的富集表达有助于促进这些细菌在婴儿体内生长。我们的数据突出了岩藻糖基化母乳聚糖在塑造婴儿肠道微生物群中的重要作用,并为中国婴儿“个性化”营养的开发提供了坚实基础。人乳聚糖为婴儿肠道微生物提供了广泛的碳源。人乳中的蛋白质糖基化水平在泌乳期间会发生变化,也可能受妊娠和泌乳阶段以及母亲分泌型状态的影响。这是第一项系统评估中国母亲在6个月泌乳期内不同分泌型状态下母乳中寡糖和岩藻糖基化N-聚糖动态变化的研究。鉴于中国人群岩藻糖基转移酶2基因上独特的单核苷酸多态性位点(rs1047781,A385T),我们的报告提供了对中国母亲母乳糖组的具体见解,这可能对婴儿肠道微生物群产生不同于其他研究队列结果的影响。